Mednet Logo
HomePrimary CareQuestion

What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?

2
1 Answers
Mednet Member
Mednet Member
Rheumatology · University of Washington

RA-ILD occurs in about 7-10% of patient with RA. It is more common in males and in those with a history of smoking. Most are seropositive. The typical pattern on HRCT in 50-60% of RA-ILD patients is a UIP pattern followed by NSIP, OP, and even LIP is some cases. An experienced clinician with the hel...

Register or Sign In to see full answer

What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)? | Mednet